BioCardia, Inc. Increase (Decrease) in Deferred Liabilities
BioCardia, Inc. (BCDA) reported Increase (Decrease) in Deferred Liabilities of -$4.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-04-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2020-04-09
- BioCardia, Inc. increase (decrease) in deferred liabilities for the quarter ending 2018-12-31 was -$3.00K, a 150.00% decline year-over-year.
- BioCardia, Inc. increase (decrease) in deferred liabilities for the quarter ending 2018-09-30 was -$4.00K, a 157.14% decline year-over-year.
- BioCardia, Inc. increase (decrease) in deferred liabilities for the quarter ending 2018-06-30 was $1.00K, a 83.33% decline year-over-year.
- BioCardia, Inc. increase (decrease) in deferred liabilities for the quarter ending 2018-03-31 was $2.00K, a 66.67% decline year-over-year.
- BioCardia, Inc. increase (decrease) in deferred liabilities for fiscal 2018 was -$4.00K, a 116.00% decline from fiscal 2017.
- BioCardia, Inc. increase (decrease) in deferred liabilities for fiscal 2017 was $25.00K, a 3.85% decline from fiscal 2016.
- BioCardia, Inc. increase (decrease) in deferred liabilities for fiscal 2016 was $26.00K.
- BioCardia, Inc. increase (decrease) in deferred liabilities for fiscal 2015 was -$23.00K.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 6 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-09 | -$7.00K derived: sum of 2 quarters · filed 2020-04-09 | -$6.00K derived: sum of 3 quarters · filed 2020-04-09 | -$4.00K 10-K · filed 2020-04-09 |
| 2018-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$3.00K derived: sum of 2 quarters · filed 2018-11-08 | -$1.00K 10-Q · filed 2018-11-08 | $5.00K derived: sum of 4 quarters · filed 2020-04-09 |
| 2018-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $3.00K 10-Q · filed 2018-08-09 | $9.00K derived: sum of 3 quarters · filed 2020-04-09 | $16.00K derived: sum of 4 quarters · filed 2020-04-09 |
| 2018-03-31 | $2.00K 10-Q · filed 2018-05-10 | $8.00K derived: sum of 2 quarters · filed 2020-04-09 | $15.00K derived: sum of 3 quarters · filed 2020-04-09 | $21.00K derived: sum of 4 quarters · filed 2020-04-09 |
| 2017-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-09 | $13.00K derived: sum of 2 quarters · filed 2020-04-09 | $19.00K derived: sum of 3 quarters · filed 2020-04-09 | $25.00K 10-K · filed 2020-04-09 |
| 2017-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $13.00K derived: sum of 2 quarters · filed 2018-11-08 | $19.00K 10-Q · filed 2018-11-08 | $67.00K derived: sum of 4 quarters · filed 2019-04-02 |
| 2017-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $12.00K 10-Q · filed 2018-08-09 | $60.00K derived: sum of 3 quarters · filed 2019-04-02 | $53.00K derived: sum of 4 quarters · filed 2019-04-02 |
| 2017-03-31 | $6.00K 10-Q · filed 2018-05-10 | $54.00K derived: sum of 2 quarters · filed 2019-04-02 | $47.00K derived: sum of 3 quarters · filed 2019-04-02 | $39.00K derived: sum of 4 quarters · filed 2019-04-02 |
| 2016-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-02 | $41.00K derived: sum of 2 quarters · filed 2019-04-02 | $33.00K derived: sum of 3 quarters · filed 2019-04-02 | $26.00K 10-K · filed 2019-04-02 |
| 2016-09-30 | -$7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$15.00K derived: sum of 2 quarters · filed 2017-11-09 | -$22.00K 10-Q · filed 2017-11-09 | |
| 2016-06-30 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$15.00K 10-Q · filed 2017-08-14 | ||
| 2016-03-31 | -$7.00K 10-Q · filed 2017-05-11 | |||
| 2015-12-31 | -$23.00K 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |